Home / Stocks / IMVT

IMVT insider trading

Immunovant, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
2
Bought · 24 mo
$686.9M
Buys · last 90 days
0 · $0
Most recent buy
2025-12-12

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-06-26Stout Jay S
Chief Technology Officer
Sold33,277$38.18$1.3M
2026-05-29Fromkin Andrew J.
Director
Sold210,468$33.56$7.1M
2025-12-12Roivant Sciences Ltd.
Director · 10% owner
Bought16,666,666$21.00$350.0M
2025-01-15Roivant Sciences Ltd.
Director · 10% owner
Bought16,845,010$20.00$336.9M

Most active insider buyers

InsiderRoleBuysTotal bought
Roivant Sciences Ltd.Director · 10% owner2$686.9M

See IMVT on the chart

Every insider buy and sell for IMVT plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.